Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA) ...

VML Health has announced the appointment of Nick Bartlett as chief executive officer of its EU hub. Bartlett holds over 20 ...

This constant barrage of new and varied challenges necessitates that medical affairs teams evaluate and communicate the ...

The value of AI in healthcare communications lies in its ability to understand what motivates, frustrates and resonates with ...

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Dive into 2025's cutting-edge medical education technologies like immersive training, interactive data visualization, and ...

Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...

The drug has been approved in combination with the chemotherapy regimen etoposide, cyclophosphamide, doxorubicin, dacarbazine ...

Dermaliq Therapeutics and global non-profit organisation DEBRA Research have entered into a partnership aimed at advancing ...

Inizio Evoke has announced the appointment of Matthew Hoelzle as chief medical officer. Hoelzle brings extensive industry ...

Many companies are working globally to widen access to clinical trials through initiatives in research and development, ...

At HCG, our goal is medical education that helps HCPs meet their patients where they are. Our commercial and marketing ...